Synthesis and molecular design of fused deazaflavin-steroid derivatives for biological and pharmacological activities
用于生物和药理活性的融合去氮黄素类固醇衍生物的合成和分子设计
基本信息
- 批准号:13672323
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This research is synthesis of the fused compounds that include two different existent physiological or pharmacological activities structurally at the same time. As a new trial in the active molecular design for drugs, I have made the plan for synthesis of such hybrid compounds like 5-deazaflavins and steroids, by expecting the bioactive potentiation or new bioactivities in the new hybrid compounds, and further I have done the search for the bioactivity of those new hybrid compounds. I describe the above research result that I got in the research period.We succeeded in the synthesis of the hybrid compounds that build in deazaflavin and steroid structures structurally at the same time. In these syntheses, we established the two kinds of simple synthetic methods. Namely the first method was the condensation of 3-morpholinoandrostene with appropriate 6-amino-5-formylpyrimidines in the presence of p-toluenesulfonic acid. The second method was the similar condensation of 2-hydroxymethylenean … More drostanolone with appropriate 6-aminopyrimidine derivatives. We tried the condensation reaction with the pyrimidine derivative and not only androstanolone but also testosterone or cholesterol derivative. The reaction has consequently been useful for the preparation of the desired hybrid compounds such as deazaflavin-androstanes and deazaflavin-cholestenes.We succeeded in the synthesis of the hybrid compounds that build in deazaflavin and steroid structures structurally at the same time. In these syntheses, we established the two kinds of simple synthetic methods. Namely the first method was the condensation of 3-morpholinoandrostene with appropriate 6-amino-5-formylpyrimidines in the presence of p-toluenesulfonic acid. The second method was the similar condensation of 2-hydroxymethyleneandrostanolone with appropriate 6-aminopyrimidine derivatives. We tried the condensation reaction with the pyrimidine derivative and not only androstanolone but also testosterone or cholesterol derivative. The reaction has consequently been useful for the preparation of the desired hybrid compounds such as deazaflavin-androstanes and deazaflavin-cholestenes.We examined the anti-coccidiosis activity for the hybrid compounds prepared here as one of search for the biological activities. Thus, some of the hybrid compounds showed more potent anti-coccidiosis activity than that of robenidine that was used as the positive control. Hereafter, the good result of the biological and pharmacological activities for these hybrid compounds will be expected. Less
本研究是在结构上同时包含两种不同存在的生理或药理活性的融合化合物的合成。作为药物活性分子设计的新尝试,我对5-去氮黄素、类固醇等杂化化合物的合成进行了计划,期待新杂化化合物的生物活性增强或新的生物活性,并对这些新杂化化合物的生物活性进行了研究。我描述了我在研究期间所获得的上述研究成果。我们成功地合成了在结构上同时包含去氮黄素和类固醇结构的杂化化合物。在这些合成中,我们建立了两种简单的合成方法。即第一种方法是在对甲苯磺酸的存在下,用适当的6-氨基-5-甲酰基嘧啶缩合3- morpholinoandrost烯。第二种方法是用合适的6-氨基嘧啶衍生物缩合2-羟亚甲基。我们尝试了嘧啶衍生物和雄甾酮衍生物以及睾酮或胆固醇衍生物的缩合反应。因此,该反应可用于制备所需的杂化化合物,如去氮黄酮-雄甾烯和去氮黄酮-胆甾烯。我们成功地合成了在结构上同时包含去氮黄素和类固醇结构的杂化化合物。在这些合成中,我们建立了两种简单的合成方法。即第一种方法是在对甲苯磺酸的存在下,用适当的6-氨基-5-甲酰基嘧啶缩合3- morpholinoandrost烯。第二种方法是2-羟亚甲基雄甾酮与合适的6-氨基嘧啶衍生物进行缩合反应。我们尝试了嘧啶衍生物和雄甾酮衍生物以及睾酮或胆固醇衍生物的缩合反应。因此,该反应可用于制备所需的杂化化合物,如去氮黄酮-雄甾烯和去氮黄酮-胆甾烯。我们对所制备的杂合物进行抗球虫活性检测,作为寻找其生物活性的手段之一。因此,一些杂交化合物的抗球虫活性比作为阳性对照的罗苯定更强。今后,这些杂交化合物的生物学和药理活性将得到良好的结果。少
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tomohisa Nagamatsu: "New Synthesis and Biologically Active Molecular Design of Deazapteridine-Steroid Hybrid Compounds"Heterocycles. 63・1. 9-16 (2004)
Tomohisa Nagamatsu:“去氮蝶啶类固醇杂化化合物的新合成和生物活性分子设计”杂环63・1。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tomohisa Nagamatsu: "New Synthesis and Biological Active Molecular Design of Deazaflavin-Steroid Hybrid Compounds"Heterocycles. 63,1. 9-16 (2004)
Tomohisa Nagamatsu:“去氮黄素-类固醇杂化化合物的新合成和生物活性分子设计”杂环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAGAMATSU Tomohisa其他文献
NAGAMATSU Tomohisa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAGAMATSU Tomohisa', 18)}}的其他基金
Molecular design and enzyme inhibition mode using software supported by computer for antitumor active flavin derivatives
计算机支持的抗肿瘤活性黄素衍生物的分子设计和酶抑制模式
- 批准号:
20590102 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular design of purines and purine nucleosides for potential xanthine oxidase inhibitory activity
具有潜在黄嘌呤氧化酶抑制活性的嘌呤和嘌呤核苷的分子设计
- 批准号:
09680570 - 财政年份:1997
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Syntheses of condensed pyrimidines as organic catalysts and the biomimetic redox catalyzed by them
有机催化剂稠合嘧啶的合成及其催化的仿生氧化还原
- 批准号:
05680505 - 财政年份:1993
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Study for Highly Stereocontrolled Reactions by Liquid Crystalline Mesophases
液晶中间相高度立体控制反应的研究
- 批准号:
62570944 - 财政年份:1987
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
NSAIDs肿瘤预防作用的非COX-2依赖性途径研究
- 批准号:30300410
- 批准年份:2003
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Genetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney Allograft
同种异体移植肾中复发性肾小球疾病的遗传学和免疫预测因子
- 批准号:
10637158 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
2023 Sex Differences in Immunity Gordon Research Conference
2023 年免疫性别差异戈登研究会议
- 批准号:
10681988 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Hormonal Contraceptives and Adolescent Brain Development
激素避孕药和青少年大脑发育
- 批准号:
10668018 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
A co-infection model for papillomavirus associated infections and cancers
乳头瘤病毒相关感染和癌症的共感染模型
- 批准号:
10667710 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
- 批准号:
10666307 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
社会经济地位较低的非裔美国人和欧洲白人胃癌风险的前瞻性代谢组学调查
- 批准号:
10912190 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Identifying mechanisms underlying sex differences in motoneuron discharge
识别运动神经元放电性别差异的机制
- 批准号:
10751793 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Effects of estrus cycle stages on murine CDI severity
发情周期阶段对小鼠 CDI 严重程度的影响
- 批准号:
10625792 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Ex vivo whole ovary culture system for screening gonadotoxicity during drug development
用于在药物开发过程中筛选性腺毒性的离体全卵巢培养系统
- 批准号:
10823136 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
- 批准号:
10733720 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别: